A robust increase in the functional expression of the neuronal KeCl cotransporter KCC2 during CNS development is necessary for the emergence of hyperpolarizing ionotropic GABAergic transmission. BDNF-TrkB signaling has been implicated in the developmental up-regulation of KCC2 and, in mature animals, in fast activity-dependent down-regulation of KCC2 function following seizures and trauma. In contrast to the decrease in KCC2 expression observed in the adult hippocampus following trauma, seizures in the neonate trigger a TrkB-dependent up-regulation of neuronal Cl À extrusion capacity associated with enhanced surface expression of KCC2. Here, we show that this effect is transient, and impaired in the hippocampus of Bdnf À/À mice. Notably, however, a complete absence of BDNF does not compromise the increase in KCC2 protein or K-Cl transport functionality during neuronal development. Furthermore, we present data indicating that the functional up-regulation of KCC2 by neonatal seizures is temporally limited by calpain activity. This article is part of the Special Issue entitled 'GABAergic Signaling in Health and Disease'.
Introduction
Progressive up-regulation of the neuron-specific multifunctional KeCl cotransporter KCC2 during rodent postnatal development is required for the emergence of hyperpolarizing GABA A receptor (GABA A R)-mediated responses in hippocampal and neocortical principal neurons (Blaesse et al., 2009; Blaesse and Schmidt, 2014; Kaila et al., 2014a; Rivera et al., 1999) . This straightforward dependence of the ontogeny of hyperpolarizing inhibition on the developmental expression of KCC2 belies a much more intricate mechanistic scenario where the expression of KCC2 protein is a necessary but not sufficient condition for the above functional outcome (Blaesse et al., 2009; Kahle et al., 2013) . For instance, work on the rodent auditory brainstem has demonstrated that, despite similarly high expression levels of KCC2 protein in the early postnatal period and during the first month of life, the capacity to extrude Cl À in neurons of the lateral superior olive emerges gradually during the first two weeks of life (Balakrishnan et al., 2003; Blaesse et al., 2006) . Indeed, mounting evidence suggests that KCC2 protein is functionally activated by phosphorylation mechanisms targeting its C-terminal domain (Chamma et al., 2012; Kahle et al., 2013; Kaila et al., 2014a; Medina et al., 2014) . Observations of this kind, underscored by the fast membrane trafficking of KCC2 (Khirug et al., 2010; Lee et al., 2007) , point to powerful post-translational control of KCC2 functionality (Blaesse et al., 2009; Kahle et al., 2013; Kaila et al., 2014a) . The development of postsynaptic GABA A R-mediated responses is also strongly influenced by the NaeKe2Cl cotransporter NKCC1. While NKCC1 has gained considerable attention in the context of neonatal seizures (for review, see Briggs and Galanopoulou, 2011; L€ oscher et al., 2013; Nardou et al., 2013; Puskarjov et al., 2014a) , only a few studies have addressed the involvement of KCC2 (Galanopoulou, 2007 (Galanopoulou, , 2008 Khirug et al., 2010; Nardou et al., 2011) . We have recently shown that a single episode of neonatal seizures in rats at postnatal day (P) 5e7 in vivo and epileptiform activity in vitro both result in enhanced membrane insertion and fast functional activation of KCC2 without altering KCC2 synthesis (Khirug et al., 2010) . The activity-dependent functional KCC2 upregulation was fully blocked by tetrodotoxin (TTX) and K252a (Khirug et al., 2010) , an efficient inhibitor of the BDNF receptor TrkB. Here we show that the rapid but transient seizure-induced functional up-regulation of KCC2 is absent in neonatal Bdnf À/À mice that show dramatically diminished TrkB signaling in early postnatal life (Di Lieto et al., 2012) . Unexpectedly (cf. Aguado et al., 2003; Ludwig et al., 2011b) Following injection, the pups were maintained for 90 min in a chamber preheated to a temperature of 33 ± 1 C. Continuous behavioral monitoring was performed throughout this period via video recording and seizure severity was scored offline.
Due to vestibular deficits, naïve Bdnf À/À mice are characterized by difficulty remaining upright and by ataxia (Ernfors et al., 1994; Jones et al., 1994) . Obviously, this precludes the use of loss of righting reflex or clonic movements for scoring of behavioral seizures. Tonic hindlimb extension, a sign of severe behavioral seizures in neonatal rodents (Velisek et al., 1995) , was not observed in naïve Bdnf À/À mice, and was used to assess the severity of seizures in Bdnf þ/þ and Bdnf À/À pups. To this end, individual video recordings were reviewed in an experimenter-blind manner at intervals of one minute. At every 60 s, the video was viewed for ten seconds and, provided during this period hindlimb tonus was observed, a score of 1 was given; otherwise the animal scored 0 for the period. A cumulative score was deduced for each animal by the sum of scores given over 90 min after injection. The latency to onset of tonic seizures was taken as the time to score two consecutive hindlimb extensions.
Preparation of acute brain slices
Coronal 400 mm thick brain slices containing the dorsal hippocampus were prepared 90 min after the injection of kainate or saline (Fig. 1A) as described previously (Khirug et al., 2010) . Following decapitation, brains were quickly removed and immersed into ice-cold physiological solution containing (in mM): 124 NaCl, 3 KCl, 2 CaCl 2 , 25 NaHCO 3 , 1.1 NaH 2 PO 4 , 2 MgSO 4 , and 10 D-glucose, equilibrated with 95% O 2 and 5% CO 2 . Slices were cut using a Campden 7000smz vibrating microtome (Campden Instruments). Before experiments were started, slices were allowed to recover for 1 h at 35 ± 1 C.
Assessment of the efficacy of neuronal Cl
To gain a quantitative estimate of the efficacy of neuronal Cl À extrusion, we used our standard assay where a constant somatic Cl À load (19 mM) is imposed on the neuron via a whole-cell patch pipette (Khirug et al., 2005) . The steepness of the ensuing bumetanide-insensitive somatodendritic E GABA gradient (DE GABA ), determined as the difference between the E GABA at the soma and at 50 mm away along the apical dendrite, has been demonstrated to provide a quantitative estimate of the efficacy of KCC2-mediated Cl À extrusion (Blaesse et al., 2006; Gauvain et al., 2011; Jarolimek et al., 1999; Khirug et al., 2005 Khirug et al., , 2008 Khirug et al., , 2010 Li et al., 2007; Puskarjov et al., 2012 Puskarjov et al., , 2014b . Whole-cell patch-clamp recordings were done in the presence of 10 mM bumetanide (Tocris) to inhibit NKCC1, 0.5 mM TTX (Abcam) to block voltage-gated Na þ channels, 10 mM CNQX (Abcam) to inhibit AMPA/kainate signaling, and 1 mM CGP 55845 (Abcam) to block GABA B receptor-mediated signaling. Part of the P6 slices were exposed to the calpain inhibitor MDL-28170 (30 mM; Tocris) (Puskarjov et al., 2012) throughout the post-recovery period and used for electrophysiological recordings or biochemical analysis during the 4th hour after recovery. After establishing whole-cell configuration, each neuron was allowed to equilibrate with the pipette solution for at least 5e10 min. The pipette solution consisted of (in mM): 18 KCl, 111 K-gluconate, 0.5 CaCl 2 , 2 NaOH, 10 glucose, 10 HEPES, 2 Mg-ATP, and 5 BAPTA, 0.1 Alexa Fluor 488; pH was adjusted to 7.3 with KOH. Data obtained from cells with stable access resistance between 10 and 20 MU and resting membrane potential below À55 mV were used for further analysis.
Membrane potential values were corrected for calculated liquid junction potentials (Barry, 1994) . Somatic and dendritic E GABA values were consecutively determined from the currentevoltage relations, obtained by sequentially clamping the membrane potential for 200 ms at six different voltage levels with a 5 mV increment and a 10 s step interval. DPNI-caged GABA (1 mM; Tocris) (Puskarjov et al., 2012; Trigo et al., 2009 Trigo et al., , 2010 was dissolved in the physiological solution containing the above drugs and delivered in the vicinity of the patched neuron at a flow rate of 1e2 ml/min via an UltraMicroPump II (WPI) equipped with a syringe and a 100 mm inner tip diameter quartz needle (WPI). To evoke local GABA A R-mediated currents at the soma or at the apical dendrite, GABA was locally uncaged using a~10 mm diameter 10 ms long UV-flash (372 nm) 50 ms after the start of each voltage step (Khirug et al., 2005; Puskarjov et al., 2012) . The 50 mm distance from the soma along the apical dendrite was traced using a Radiance 2100 confocal microscope (Bio-Rad) and Alexa Fluor 488 in the patch pipette (Khirug et al., 2008; Puskarjov et al., 2012 ).
An earlier study reported a gender-related difference in the reversal potentials of GABA A R-mediated currents in CA1 pyramidal neurons of P4e7 rats that had undergone multiple saline injections (Galanopoulou, 2008) . However, presently, no significant difference in the Cl À extrusion capacity of CA1 pyramidal neurons between P6 male and female Bdnf þ/þ mice was observed after a single injection of saline (DE GABA in males: À3.03 ± 0.24 mV/50 mM; n ¼ 11 neurons; DE GABA in females: À3.54 ± 0.32 mV/50 mM; n ¼ 13 neurons; p ¼ 0.232; ManneWhitney Rank Sum Test). Thus, data from male and female mice were pooled in the present study.
Analysis of KCC2 surface expression
A protease approach (Ahmad et al., 2011; Khirug et al., 2010; Puskarjov et al., 2012) was used to measure the surface expression of KCC2. In brief, 30 min after recovery, slices were treated with cod trypsin (Zymetech), a cold-adapted protease that retains its activity at low temperatures while trafficking of membrane proteins is prevented (Ahmad et al., 2011) . Slices were incubated on ice for 60 min in the presence of cod trypsin (2 U/ml). The cleavage reaction was stopped by adding the trypsin inhibitor phenylmethylsulfonyl fluoride (100 mM; 5 min on ice). After homogenization the samples were analyzed using immunoblotting.
Quantitative immunoblotting
Immunoblot analysis was performed on hippocampal slices and whole hippocampi as described previously (Puskarjov et al., 2012) . A polyclonal rabbit-antipanKCC2 antibody (1:1000; Ludwig et al., 2003) was used for KCC2 and rabbitanti tubulin (1:20,000; Nordic BioSite, catalog #PRB-435P) for reference. For some blots, affinity-purified rabbit-anti-panKCC2 antibody was used to detect the cod trypsin cleavage product of KCC2. The secondary antibody used was horseradish peroxidase-conjugated donkey-anti-rabbit IgG (1:3000; GE Healthcare). Immunoreactivity was detected using an enhanced chemiluminescence detection kit (Pierce) and a LAS-3000 documentation system (Fujifilm). Quantification was performed using AIDA software (Raytest).
Results

Seizure-induced activation of KCC2 is impaired in the neonatal
Consistent with previous work in P5-7 rats (Khirug et al., 2010) Barton and Shannon (2005) of no difference between BDNFdeficient and wildtype mice in seizure thresholds for tonic-clonic seizures induced by electrical stimulation. The above results suggests that under the present conditions, the difference in KCC2 activation between the two genotypes is unlikely to stem from differences in the severity of the seizures experienced by the Bdnf À/À and Bdnf þ/þ animals.
The seizure-induced enhancement of neuronal Cl À extrusion capacity in neonatal rats is not associated with increased KCC2 total protein, but it is paralleled by a robust increase in the surface expression of KCC2 that is sensitive to TTX and the kinase inhibitor K252a (Khirug et al., 2010 Fig. 2B; 80.1 ± 5% at 240 min of the level measured immediately after recovery [0 min in Fig. 1A ] in slices from the same animal; n ¼ 10 slices for both groups; p ¼ 0.011; one-way repeated measures ANOVA with Tukey's post hoc test). This effect is unlikely to be attributable to putative progressive deterioration of brain tissue due to damage caused by slicing as evidenced by the fact that, under control conditions in hippocampal slices, the total and functional KCC2 protein pools are stable for several hours (Puskarjov et al., 2012) . Recent work (Chamma et al., 2013; Puskarjov et al., 2012; Zhou et al., 2012) has shown that KCC2 is down-regulated by the Ca 2þ -activated protease calpain as a consequence of strongly enhanced glutamatergic signaling. Kainate-induced seizure activity has been reported to result in calpain activation in the CA1 stratum radiatum of P7 rats 4 h after seizure onset (Bi et al., 1997 ). Thus, we tested whether the delayed down-regulation of KCC2 following neonatal seizures is sensitive to the calpain inhibitor MDL-28170 applied immediately after recovery. In the absence of calpain activity, significantly higher DE GABA values were observed in slices from kainate-injected Bdnf þ/þ animals during the 4th hour after recovery ( Fig. 2A; À5.18 ± 0.31 mV/50 mm; n ¼ 6 neurons; p ¼ 0.003, vs.
respective 180e240 min values without MDL-28170; one-way ANOVA with Holm-Sidak post hoc test). Likewise, down-regulation of KCC2 protein was fully blocked by MDL-28170 ( Fig. 2B ; 109 ± 6.4% of the level measured at 0 min; n ¼ 10 slices; p ¼ 0.965 and 0.006, respectively, vs. levels in slices from the same animal at 0 and 240 min after recovery; one-way repeated measures ANOVA with Tukey's post hoc test). It has been previously demonstrated that, under control conditions, blocking protein degradation, including constitutive calpain activity, does not result in significant up-regulation of KCC2 protein in the present timescale of 4 h (Puskarjov et al., 2012) , suggesting that the effect obtained with MDL-28170 is unlikely to be accounted by unmasking of KCC2 de novo synthesis. incubated slices from kainate-injected Bdnf þ/þ animals were significantly higher than those measured during the 4th hour without MDL and remained at the level of the 0e90 min group (see Fig. 1F) . B, Down-regulation of KCC2 total protein observed at the 4th hour after recovery in slices from kainate-injected Bdnf þ/þ animals is prevented by MDL-28170.
Representative Western blot analysis and quantification of KCC2 total protein after the seizure episode in Bdnf þ/þ slices incubated for 4 h with MDL or DMSO. Signal intensity at 240minutes ± MDL was normalized with respect to Bdnf þ/þ to the 0 min level in slices from the same animal. *p < 0.05; **p < 0.01. Error bars denote SEM.
Developmental up-regulation of KCC2 takes place in the Bdnf
À/À hippocampus Overexpression or exogenous application of BDNF has been reported to result in increased KCC2 mRNA and protein levels, suggesting that BDNF may play a role in the developmental expression of KCC2 protein (Aguado et al., 2003; Ludwig et al., 2011b) . To investigate the possibility that the lack of seizure-induced functional activation of KCC2 may be a consequence of compromised developmental up-regulation of KCC2 in Bdnf À/À mice, we analyzed the total hippocampal KCC2 protein levels between naïve (non-injected) Bdnf À/À mice and their wildtype littermates at P5-6 and P13-14.
Differences in the total protein levels of KCC2 between the two genotypes were observed neither at P5-6 nor at P13-14 ( Figs. 3A and neurons (Khirug et al., 2005) , no difference was observed in DE GABA between the two genotypes ( Fig. 3C ; Bdnf À/À : À9.91 ± 0.78 mV/ 50 mm; n ¼ 11 neurons; Bdnf þ/þ : À9.71 ± 1.04 mV/50 mm; n ¼ 6 neurons; p ¼ 0.44; one-tailed Student's t-test).
Discussion
We show here that the fast functional up-regulation of KCC2 in the mouse hippocampus following neonatal status epilepticus is dependent on BDNF. In our previous experiments, both a kainateinduced seizure episode in P5-7 rats and seizure-like activity induced via kainate application to brain slices led to a rapid enhancement of the efficacy of neuronal Cl À extrusion capacity and to a hyperpolarizing E GABA shift in CA1 pyramidal neurons. This was accompanied by a large increase in the surface expression of KCC2 (Khirug et al., 2010) . Interestingly, a similar effect has been recently described in P5-7 rat motoneurons in the context of spinal cord injury (Bos et al., 2013) , suggesting that in the neonate this may be a general first-in-line neuronal response to seizures and trauma (cf. Kaila et al., 2014b) . After the initial functional up-regulation of KCC2 observed in the present study, a progressive calpain-dependent down-regulation of KCC2 protein and neuronal Cl À extrusion capacity ensued. This is in accord with the reported down-regulation of KCC2 in the intact neonatal hippocampal preparation following sustained kainate-triggered ictal events (Nardou et al., 2011) and the calpain-dependency of KCC2 down-regulation in CA1 pyramidal neurons of juvenile rats (Puskarjov et al., 2012) . Indeed, a recent study demonstrated that hippocampal KCC2 is targeted by calpain-mediated cleavage in a rat model of late gestation hypoxia-ischemia (Jantzie et al., 2014) , and this may well represent a mechanism that contributes to the brain damage-related down-regulation of KCC2 in human babies (Robinson et al., 2010) . Our previous work demonstrated that both the increase in surface expression of KCC2 and the enhanced Cl À extrusion capacity were abolished by the kinase inhibitor K252a. By contrast, in mature hippocampal neurons this drug has been shown to prevent TrkB-mediated down-regulation of KCC2 induced by exogenous BDNF or NT-4 (Rivera et al., 2002) or endogenous BDNF following NMDA receptor activation (Rivera et al., 2004) . In these cells, BDNFinduced down-regulation of KCC2 appears to require activation of the TrkB-phospholipase-Cg1 (PLCg1) signaling pathway that is heavily implicated in the process of epileptogenesis Rivera et al., 2004) . BDNF has been shown to exert a developmental stage-dependent effect also on the function of GABA A Rs. While at P6 BDNF rapidly potentiates GABA A R-mediated currents of CA1 pyramidal neurons, by P10 this effect is lost, and from~P14 onwards BDNF suppresses GABA A R function (Mizoguchi et al., 2003) . This kind of striking age-dependent co-regulation of KCC2 and GABA A Rs is in line with the qualitative change in BDNFTrkB signaling that takes place around P12 in the rodent hippocampus and cortex (Di Lieto et al., 2012; Knüsel et al., 1994) , and may in part be explained by the apparently age-dependent response of TrkB phosphorylation at its PLCg1 binding site (Di Lieto et al., 2012) . Findings of the above kind may also shed light on the mechanisms which underlie the well-known differences between seizures in neonates and adults that have been observed in neurological and pharmacological work (cf. Haut et al., 2004; L€ oscher et al., 2013; Volpe, 2008) . Thus, the present data and those by Mizoguchi et al. (2003) suggest that, in a manner opposite to what is observed in adults, seizure-induced release of BDNF in the early postnatal period enhances the efficacy of inhibition by increasing the amplitude of the GABA A R-mediated current and by inducing a negative shift in its reversal potential.
Another key finding in the present work is that the developmental up-regulation of hippocampal KCC2 protein and transport functionality takes place in the complete absence of BDNF expression in vivo. This indicates that although BDNF has been shown to exert an accelerating effect on neuronal development including the up-regulation of KCC2 (Aguado et al., 2003; Kaila et al., 2014a; Ludwig et al., 2011b) , it is not a necessary component for KCC2 up-regulation to take place during ontogenesis. Indeed, other trophic factors act in a parallel and apparently redundant manner with KCC2-regulating transcriptional pathways downstream of BDNF (Ludwig et al., 2011a) . Reduction in BDNF expression has been previously shown to result in a decrease of both frequency and amplitude of GABAergic inhibitory postsynaptic currents in various central neurons (e.g. Abidin et al., 2008; Laudes et al., 2012) . The present observations suggest that such effects are unlikely to be a consequence of reduced neuronal Cl À extrusion.
